Key Biotech Updates: Lawsuits and Regulatory Challenges
Today's biotech news highlights a lawsuit concerning Duchenne therapy and challenges faced by FDA Commissioner Marty Makary in relation to the White House.
Editorial Staff
1 min read
Updated 1 day ago
In recent biotech news, a lawsuit has emerged regarding a therapy for Duchenne muscular dystrophy, raising questions about its implications for the industry.
Additionally, FDA Commissioner Marty Makary is reportedly facing difficulties connected to his role in the White House, which may affect regulatory processes.
These developments, along with other updates, underscore the ongoing complexities in the biotech sector and the regulatory landscape.